Plus Therapeutics, Inc. (PSTV) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Find Plus Therapeutics, Inc. (PSTV) short-term stock forecasts for 2025 by month and long-term price predictions for 2025 to 2050. View past performance, analyst Buy, Sell or Hold ratings, and the latest PSTV stock news and headlines.
1 Month Prediction
$2.89 [100.49%]
3 Month Prediction
$2.45 [70.11%]
6 Month Prediction
$2.29 [58.84%]
1 Year Prediction
$1.67 [15.94%]
3 Year Prediction
$1.00 [-30.56%]
5 Year Prediction
$1.00 [-30.56%]
About Plus Therapeutics, Inc.
Plus Therapeutics, Inc. is a U.S. clinical-stage pharmaceutical company that develops innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. The company uses nanoliposome-encapsulated Rhenium-186, a radioisotope emitting beta particles with a short half-life, suitable for treating solid tumors.
Their main radiotherapeutic candidate, Rhenium (186Re) Obisbemeda, targets central nervous system cancers for treating conditions like glioblastoma and leptomeningeal metastases.
The company is based in Houston, Texas, with roots in Austin.
Plus Therapeutics, Inc. (PSTV) Historical Performance
Change
Since inception, PSTV has decreased by 100.00%. In the last 5 years, PSTV has fallen from $24.15 to $1.44, a massive -94.04% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $42.75 and a low of $0.73.
52 Week Range
$0.24
$2.67
The current price $1.44 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
PSTV Stock Price History
Based on PSTV stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the PSTV stock has fallen from $24.0 - $38.4 to $0.73 - $1.44, which is down -99.09%. Currently, the stock follows downward trend.
Here, we have calculated stock range of PSTV, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $24.0 - $38.4 | $31.31 | -75.0 | 1 Year Change |
| 2021 | $15.75 - $42.75 | $31.35 | -74.97 | 2 Year Change |
| 2022 | $4.8 - $15.6 | $9.65 | -92.3 | 3 Year Change |
| 2023 | $1.22 - $6.45 | $3.09 | -97.53 | 4 Year Change |
| 2024 | $1.15 - $2.21 | $1.64 | -98.69 | 5 Year Change |
| 2025 | $0.73 - $1.44 | $1.14 | -99.09 | 6 Year Change |
PSTV Price Performance
6-Month Performance
PSTV stock jumped by 9.09% in the last six months.
1-Year Performance
The stock has trended downwards by 17.24% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 85.67%.
5-Year Performance
In the last 5 years, the stock has gone down by 94.04%.
According to Plus Therapeutics, Inc.'s historical data, below graph gives us the exact picture of how the PSTV stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 0 year and a decline in 5 years.
2020
15.83% ↓
2021
48.02% ↓
2022
69.52% ↓
2023
63.54% ↓
2024
34.29% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Plus Therapeutics, Inc. (PSTV) Financials & Stock Analysis
Market Capitalization
Plus Therapeutics, Inc. has a market capitalization of $8.49M, which places PSTV in the nano-cap category.
Fundamental Analysis
EPS: $-0.37 (Q3), $-4.24 (1Y)
EPS decreased 17.78% since last quarter, and decreased 63.29% since last year.
Net Income: $-2.87 M (Q3), $-13.32 M (1Y)
Net Income decreased 2.24% since last quarter, and decreased 34.32% since last year.
Free Cash Flow: $-3.69 M (Q3), $-13.01 M (1Y)
Free Cash Flow increased N/A since last quarter, and decreased 5.24% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for PSTV stock. These indicators help you understand Plus Therapeutics, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for PSTV stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $1.02 |
| SMA50 | $1.12 |
| SMA200 | $1.46 |
| RSI | 55.31 |
| Beta | 0.73 |
SMA20 < Current Price
This signals PSTV stock is in short-term bullish momentum.
SMA50 < Current Price
This signals PSTV stock is in mid-term bullish momentum.
SMA200 > Current Price
This signals PSTV stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for PSTV stock is Bearish. Out of all indicators, 2 indicates bullish signals, 4 signals bearish trends and 3 gives neutral trends. The PSTV stock forecast was last updated on 07 March, 2025.
Plus Therapeutics, Inc. (PSTV) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $1.78 by the end of 2025, and can reach around $2.85 to $0.88 in 2026. And, the long-term forecast suggests that the stock may further drop to $1.21 - $0.83 in 2028, and $1.50 - $1.63 by 2031. So, the PSTV stock shows a strong upward trend in the next several years.
Short-term PSTV Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-04 | $2.89 | 100.69% |
| 2025-05 | $3.27 | 127.08% |
| 2025-06 | $2.45 | 70.14% |
| 2025-07 | $2.72 | 88.89% |
| 2025-08 | $2.31 | 60.42% |
| 2025-09 | $2.29 | 59.03% |
| 2025-10 | $1.23 | -14.58% |
| 2025-11 | $1.75 | 21.53% |
| 2025-12 | $1.78 | 23.61% |
In 2025, the PSTV stock price is expected to fluctuate between $1.23 and $3.27. According to the monthly forecast, the stock could rise to $1.78 by December 2024. If compared to the PSTV's current price, the stock could gain 23.61% by the end of this year.
Long-term PSTV Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $2.85 | $2.07 | $0.88 | -38.89% |
| 2027 | $0.55 | $0.92 | $0.80 | -44.44% |
| 2028 | $1.21 | $1.35 | $0.83 | -42.36% |
| 2029 | $1.08 | $1.22 | $1.23 | -14.58% |
| 2030 | $0.98 | $1.39 | $1.18 | -18.06% |
| 2031 | $1.50 | $1.62 | $1.63 | 13.19% |
| 2032 | $0.61 | $0.75 | $1.41 | -2.08% |
| 2033 | $1.17 | $1.35 | $1.13 | -21.53% |
| 2034 | $1.20 | $0.75 | $1.23 | -14.58% |
| 2035 | $0.98 | $0.57 | $1.00 | -30.56% |
| 2036 | $0.82 | $0.83 | $0.90 | -37.5% |
| 2037 | $1.31 | $0.61 | $0.88 | -38.89% |
| 2038 | $0.98 | $1.35 | $1.02 | -29.17% |
| 2039 | $1.33 | $0.92 | $0.86 | -40.28% |
| 2040 | $0.94 | $0.55 | $0.96 | -33.33% |
| 2041 | $0.98 | $1.51 | $0.61 | -57.64% |
| 2042 | $1.26 | $0.66 | $1.43 | -0.69% |
| 2043 | $0.81 | $1.12 | $0.41 | -71.53% |
| 2044 | $0.89 | $1.63 | $1.26 | -12.5% |
| 2045 | $1.20 | $1.14 | $1.31 | -9.03% |
| 2046 | $1.11 | $0.94 | $0.93 | -35.42% |
| 2047 | $1.28 | $1.20 | $1.46 | 1.39% |
| 2048 | $0.95 | $0.83 | $1.19 | -17.36% |
| 2049 | $0.84 | $1.07 | $0.82 | -43.06% |
| 2050 | $1.17 | $0.56 | $1.02 | -29.17% |
| 2051 | $1.01 | $0.89 | $1.15 | -20.14% |
Plus Therapeutics, Inc. (PSTV) Stock Price Prediction & Forecast 2025
At the start of 2025, the PSTV stock was at $1.24. Today, it is trading at $1.44, which is 16.13% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $1.78 by December 2025 with a 23.61% change.
Plus Therapeutics, Inc. (PSTV) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the PSTV stock. During this period, the PSTV's price is forecasted to shift from $2.85 to $1.18, which is -58.60% loss.
In 2026, the stock would possibly open at $2.85, descends to $2.07 by mid-year, and wraps up at $0.88, reflecting a decrease from today's price. Further moving to 2030, the stock can kick off the year at $0.98, drop to $1.39 by mid-year, and finish at $1.18, which is -18.09% change from current price.
Plus Therapeutics, Inc. (PSTV) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $1.50 to $0.96, which is down 13.25%
In 2031, we can expect PSTV to fluctuate between $1.50 and $1.63, a shift indicating a 13.25% gain by year-end compared to current price. And Until 2040, PSTV can likely vary from $0.94 to $0.96. By the end of 2040, the stock could record a -33.25% fall from today's stock price.
Plus Therapeutics, Inc. (PSTV) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the PSTV stock can see an an upturn from $0.98 to $1.02 in this period. In 2041, the stock can experience a high of $1.51 by mid-year, closing the year at $0.61. This results in a 4.77% increase from today.
Moving towards the end of 2050, PSTV is projected to open the year at $1.17. The stock may dip to $0.56 during mid-year and finish the year at $1.02. Compared to the stock's current price, this translates to an overall loss of -28.92% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
PSTV Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| TNYA | Tenaya Therapeutics, Inc. | - | $0.46 | -54.95% ▼ | $790.53 ▲ |
| MRSN | Mersana Therapeutics, Inc. | - | $0.54 | 4.07% ▲ | $519.39 ▲ |
| XERS | Xeris Biopharma Holdings, Inc. | - | $4.13 | 7.83% ▲ | $41.7 ▲ |
| NTLA | Intellia Therapeutics, Inc. | - | $9.10 | -9.86% ▼ | $208.86 ▲ |
| ONVO | Organovo Holdings, Inc. | - | $1.27 | 252.78% ▲ | -3.29 ▼ |
Last updated Mar 07 at 2:06 PM
PSTV : Buy, Sell Or Hold?
Analyst Ratings
Based on 3 analysts, 1 rated as a strong buy, 2 recommended a buy, 0 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.So, according to analyst ratings, the recommendation for PSTV stock is Buy.
Expert Analysis
According to PSTV short-term and long-term forecast, Plus Therapeutics, Inc. shares are projected to go down by 29.17%, and reach a value of $1.02 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 21.428571428571427, which signals Fear. Also, PSTV has recorded 7/30 green days, which reflects a 31.818181818181817% positivity rate with a price volatility of 0.59%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that PSTV stock is undervalued. So, Based on PSTV prediction and analysis, it may be the best time to sell PSTV stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "PSTV” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.